Full Coverage

Sort

News about Iveric Bio

Astellas Pharma buys Iveric Bio for $5.9 billion

May 1, 2023

By Rocky Swift

Financial Times

Financial Times

Financial Times

Japan's Astellas to buy US biotech group Iveric Bio for $5.9bn

May 1, 2023

By Kana Inagaki

PR Newswire

PR Newswire

Astellas Enters into Definitive Agreement to Acquire Iveric Bio

Apr 30, 2023

For you Top stories Local Following

Search

Clear search

Close search

Google apps

Main menu